Table 4 Data on mean (SD) primary outcome measures at 3 and 6-months follow-up in the intervention group (n = 71) and control group (n = 75) and the estimated effect of the multidisciplinary lifestyle intervention on cardiovascular risk factors compared with the control group
Primary outcome measure | Baseline | Â | Baseline to 3 months | Â | 6-months | Â |
|---|---|---|---|---|---|---|
|  | Intervention, n = 71 mean (SD) | Control, n = 75 mean (SD) | Intergroup differencesaB(95% CI) | p | Intergroup differencesaB(95% CI) | p |
Weight, kg | 86.0 (15.0) | 88.0 (20.6) | −1.3 (−2.2/-0.4)** b | 0.004 | −1.3 (−2.5/-0.1)**b | 0.03 |
Body mass index, kg/m 2 | 28.7 (4.4) | 29.8 (5.4) | −0.5 (−0.8/-0.2)** b | 0.002 | −0.5 (−0.9/-0.1)**b | 0.02 |
Waist circumference, cm | 101.2 (13.4) | 101.0 (14.7) | −2.5 (−4.0/-1.0)** | 0.001 | −0.2 (−2.0/1.6)** | 0.82 |
Systolic BP, mmHg | 137.8 (20.5) | 140.0 (18.2) | −3.6 (−7.9/0.7) | 0.10 | −2.7 (−8.0/2.5) | 0.30 |
Diastolic BP, mmHg | 80.2 (10.1) | 79.3 (10.5) | −1.7 (−4.0/0.6) | 0.15 | −1.0 (−3.9/1.8) | 0.47 |
Total cholesterol, mmol/l | 4.2 (0.8) | 4.6 (1.1) | −0.1 (−0.3/0.2) | 0.55 | −0.2 (−0.5/0.1) | 0.25 |
HDL cholesterol, mmol/l | 1.3 (0.3) | 1.4 (0.4) | 0.02 (−0.1/0.1) | 0.68 | −0.0001 (−0.1/0.1) | 0.99 |
Cholesterol/HDL ratio | 3.3 (0.9) | 3.4 (1.1) | 0.06 (−0.2/0.3) | 0.61 | −0.1 (−0.4/0.2) | 0.58 |
LDL cholesterol, mmol/l | 2.2 (0.8) | 2.4 (1.0) | 0.001 (−0.2/0.2) | 0.99 | −0.1 (−0.3/0.2) | 0.61 |
HbA1c,% 1 | 7.1 (1.8) | 7.1 (1.3) | −0.3 (−0.9/0.4) | 0.38 | −0.5 (−1.2/0.2) | 0.14 |
Maximal work rate,Watt | 146.1 (43.5) | 156.4 (49.4) | 6.9 (0.9/13.0)** | 0.03 | n.a. | Â |
Maximal ergometry, METS | 6.4 (1.6) | 6.7 (1.8) | 0.3 (0.1/0.5)** | 0.01 | n.a. | Â |